TSX:DNTL - Post Discussion
Post by
retiredcf on Mar 28, 2022 8:42am
Two More Upgrades
TD Securities analyst Daryl Young raised his Dentalcorp Holdings Ltd. target by $1 to $20, keeping a “buy” rating, while Scotia’s Patricia Baker also bumped her target to $20 from $19 with a “sector outperform” rating. The average is $20.50.
“With 1.7M active patients currently and 4 million visits per year, DNTL is set to see continued outsized growth in the Canadian dental market through its M&A activity, and drive organic growth through operating efficiencies, as well as drive longer term growth with expansion of its proprietary model to other verticals. DNTL noted the current M&A pipeline is strong with more than 150 potential opportunities in advanced discussions, indicating F22 is likely to be a very solid year for DNTL with respect to bolstering its Canadian network via further accretive M&A,” said Ms. Baker.
Be the first to comment on this post